Holen Sie sich die Stockscreener-App
9.09
0.89%
0.08
Handel nachbörslich:
9.09
Schlusskurs vom Vortag:
$9.01
Offen:
$9.03
24-Stunden-Volumen:
60,304
Relative Volume:
0.52
Marktkapitalisierung:
$131.06M
Einnahmen:
$166.88M
Nettoeinkommen (Verlust:
$-74.18M
KGV:
-1.7929
EPS:
-5.07
Netto-Cashflow:
$1.14M
1W Leistung:
-1.52%
1M Leistung:
+3.65%
6M Leistung:
-46.09%
1J Leistung:
-63.90%
1-Tages-Spanne:
$9.03
$9.185
1-Wochen-Bereich:
$8.91
$9.5389
52-Wochen-Spanne:
$7.8701
$26.00
Anika Therapeutics Inc Stock (ANIK) Company Profile
Firmenname
Anika Therapeutics Inc
Sektor
Telefon
(781) 457-9000
Adresse
32 WIGGINS AVENUE, BEDFORD, MA
Vergleichen Sie ANIK mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ANIK
Anika Therapeutics Inc
|
9.09 | 131.93M | 166.88M | -74.18M | 1.14M | -5.07 |
|
ZTS
Zoetis Inc
|
153.20 | 67.75B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.29 | 47.88B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.84 | 43.70B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.48 | 21.51B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
380.47 | 18.31B | 2.99B | 1.21B | 1.13B | 25.06 |
Anika Therapeutics Inc Stock (ANIK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-17 | Eingeleitet | B. Riley Securities | Buy |
| 2024-11-01 | Bestätigt | Barrington Research | Outperform |
| 2023-08-14 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2023-03-07 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2022-11-09 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2022-10-14 | Fortgesetzt | Stephens | Equal-Weight |
| 2022-03-09 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2022-03-09 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2021-11-16 | Eingeleitet | Stephens | Overweight |
| 2021-07-16 | Eingeleitet | UBS | Neutral |
| 2020-12-16 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2020-05-08 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2020-01-21 | Hochstufung | Sidoti | Neutral → Buy |
| 2020-01-10 | Hochstufung | First Analysis Sec | Outperform → Strong Buy |
| 2019-11-05 | Eingeleitet | BWS Financial | Sell |
| 2019-09-24 | Bestätigt | Barrington Research | Outperform |
| 2019-09-23 | Herabstufung | First Analysis Sec | Strong Buy → Outperform |
| 2019-07-25 | Hochstufung | First Analysis Sec | Neutral → Strong Buy |
| 2019-02-22 | Herabstufung | First Analysis Sec | Outperform → Neutral |
| 2019-02-22 | Herabstufung | Sidoti | Buy → Neutral |
| 2018-07-27 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2018-06-20 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2018-06-20 | Herabstufung | First Analysis Sec | Overweight → Equal-Weight |
| 2018-05-04 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2018-02-23 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2018-01-24 | Hochstufung | First Analysis Sec | Equal-Weight → Overweight |
| 2017-10-27 | Bestätigt | Barrington Research | Outperform |
| 2016-05-09 | Hochstufung | Singular Research | BUY - Long-Term → Buy |
| 2016-04-27 | Herabstufung | Northland Capital | Outperform → Market Perform |
| 2016-02-26 | Bestätigt | Barrington Research | Outperform |
Alle ansehen
Anika Therapeutics Inc Aktie (ANIK) Neueste Nachrichten
Is Anika Therapeutics Inc. gaining market shareBreakout Watch & Fast Entry and Exit Trade Plans - khodrobank.com
Risk adjusted return profile for Anika Therapeutics Inc. analyzedTrade Volume Summary & Consistent Profit Alerts - Newser
What data driven models say about Anika Therapeutics Inc.’s futureLong Setup & Consistent Income Trade Ideas - Newser
Will Anika Therapeutics Inc. rebound enough to break evenWeekly Volume Report & High Conviction Buy Zone Picks - Newser
Real time breakdown of Anika Therapeutics Inc. stock performanceSell Signal & Daily Growth Stock Investment Tips - Newser
Visual analytics tools that track Anika Therapeutics Inc. performanceJuly 2025 Breakouts & Weekly Watchlist of Top Performers - Newser
Statistical indicators supporting Anika Therapeutics Inc.’s strengthWeekly Gains Report & Weekly Watchlist for Hot Stocks - Newser
How institutional ownership impacts Anika Therapeutics Inc. stock2025 Stock Rankings & Community Trade Idea Sharing Platform - Newser
Applying big data sentiment scoring on Anika Therapeutics Inc.Weekly Gains Report & Risk Controlled Stock Pick Alerts - Newser
Will Anika Therapeutics Inc. price bounce be sustainableWeekly Trade Report & Free Safe Capital Growth Stock Tips - Newser
Is Anika Therapeutics Inc. stock entering bullish territoryMarket Movers & Advanced Swing Trade Entry Plans - Newser
Will Anika Therapeutics Inc. benefit from geopolitical trendsInsider Selling & Daily Profit Focused Screening - khodrobank.com
Will Anika Therapeutics Inc. stock recover after recent dropSwing Trade & Accurate Intraday Trading Signals - Newser
Real time scanner hits for Anika Therapeutics Inc. explainedQuarterly Market Review & Smart Allocation Stock Tips - Newser
Tools to monitor Anika Therapeutics Inc. recovery probabilityJuly 2025 Recap & Expert Curated Trade Ideas - Newser
Is Anika Therapeutics Inc. forming a bottoming base2025 Winners & Losers & Long-Term Growth Plans - Newser
Tick level data insight on Anika Therapeutics Inc. volatility2025 Stock Rankings & Real-Time Volume Triggers - Newser
Is Anika Therapeutics Inc. stock bottoming outJuly 2025 Fed Impact & AI Powered Market Entry Strategies - Newser
Understanding Anika Therapeutics Inc.’s price movementJuly 2025 Trends & Low Risk Profit Maximizing Plans - Newser
Using fundamentals and technicals on Anika Therapeutics Inc.2025 Historical Comparison & Free Expert Approved Momentum Trade Ideas - Newser
Can a trend reversal in Anika Therapeutics Inc. lead to recoveryWeekly Risk Report & Trade Opportunity Analysis Reports - Newser
Applying Wyckoff theory to Anika Therapeutics Inc. stockPortfolio Profit Report & Free Community Consensus Stock Picks - Newser
Aug Ideas: What are Anika Therapeutics Inc.’s technical support levels - khodrobank.com
What are Anika Therapeutics Inc.’s recent SEC filings showing2025 Market WrapUp & Weekly Consistent Profit Watchlists - khodrobank.com
Can you recover from losses in Anika Therapeutics Inc.Market Rally & Weekly Top Stock Performers List - Newser
Will Anika Therapeutics Inc. outperform the market in YEARJuly 2025 Opening Moves & Stepwise Trade Signal Guides - khodrobank.com
How to integrate Anika Therapeutics Inc. into portfolio analysis toolsJuly 2025 PreEarnings & Risk Controlled Daily Plans - Newser
Pomerantz LLP Investigates Anika Therapeutics Securities Fraud Claims - AInvest
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc.ANIK - FinancialContent
What is the target price for Anika Therapeutics Inc. stockFed Meeting & Weekly Setup with ROI Potential - khodrobank.com
Can Anika Therapeutics Inc. expand into new marketsMarket Performance Recap & Daily Price Action Insights - khodrobank.com
How to forecast Anika Therapeutics Inc. trends using time series2025 Technical Overview & Smart Investment Allocation Tips - Newser
Anika Therapeutics Inc. Hits Oversold Level on RSI Indicator getLinesFromResByArray error: size == 0 - kangso.co.kr
Technical analysis overview for Anika Therapeutics Inc. stockPortfolio Update Summary & Real-Time Chart Pattern Alerts - Newser
Regression analysis insights on Anika Therapeutics Inc. performance2025 Volume Leaders & Low Risk High Win Rate Stock Picks - Newser
Growth Review: What are Anika Therapeutics Inc.’s technical support levels2025 Price Momentum & Real-Time Volume Analysis - khodrobank.com
How hedge fund analytics apply to Anika Therapeutics Inc. stockWeekly Trend Summary & Daily Volume Surge Signals - Newser
Published on: 2025-08-31 17:39:40 - Newser
Has Anika Therapeutics Inc. found a price floor2025 Momentum Check & Verified High Yield Trade Plans - Newser
Finanzdaten der Anika Therapeutics Inc-Aktie (ANIK)
Umsatz
Nettogewinn
Free Cashflow
ENV
Anika Therapeutics Inc-Aktie (ANIK) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Nunes Anne | SVP, Chief Operations Officer |
Mar 17 '25 |
Option Exercise |
0.00 |
3,637 |
0 |
21,722 |
| Colleran David | EVP, General Counsel, Corp Sec |
Mar 17 '25 |
Option Exercise |
0.00 |
6,448 |
0 |
49,847 |
| Blanchard Cheryl R | President, CEO, Director |
Mar 17 '25 |
Option Exercise |
0.00 |
25,132 |
0 |
209,472 |
| Nunes Anne | SVP, Chief Operations Officer |
Mar 11 '25 |
Option Exercise |
0.00 |
2,561 |
0 |
18,837 |
| Colleran David | EVP, General Counsel, Corp Sec |
Mar 11 '25 |
Option Exercise |
0.00 |
7,663 |
0 |
45,649 |
| Blanchard Cheryl R | President, CEO, Director |
Mar 11 '25 |
Option Exercise |
0.00 |
30,060 |
0 |
197,015 |
| Nunes Anne | SVP, Chief Operations Officer |
Mar 10 '25 |
Option Exercise |
0.00 |
3,296 |
0 |
17,235 |
| Colleran David | EVP, General Counsel, Corp Sec |
Mar 10 '25 |
Option Exercise |
0.00 |
5,465 |
0 |
39,590 |
| Blanchard Cheryl R | President, CEO, Director |
Mar 10 '25 |
Option Exercise |
0.00 |
20,002 |
0 |
172,826 |
| Nunes Anne | SVP, Chief Operations Officer |
Oct 01 '24 |
Option Exercise |
0.00 |
2,491 |
0 |
14,211 |
3.60%
0.69%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):